About
Technology
Issues
FAQ
Links
Official Page
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.